IL1B and early-onset autosomal dominant Alzheimer disease: Different studies have linked the deleterious effects of IL-1β with different pathological conditions, including type 1 diabetes [71,72], gout [73], Alzheimer’s disease [74] and many auto-inflammatory disorders [75].